Vinorelbine

Title	Average Rating
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled	80.00%
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast ca	80.00%
CECs, CEPs and CTCs for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic vinorelbine.	60.00%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer.	60.00%
A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients...............	50.00%
A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.	40.00%

Languages